 |
|
|
| |
Doravirine plus raltegravir (DOR/RAL) two-drug regimen as a maintenance ART in virally suppressed PWH: results of the international randomised DORAL trial
|
| |
| |
R. Palich1, A. Castagna2, C. Allavena3, A. Antinori4, D. Canetti2, J. Tiraboschi5, C. Duvivier6, E. Martinez7,
P. Domingo8, S. Barkat9, Y. Dudoit1, L. Béniguel9, G. Peytavin10, C. Soulié11, A.-G. Marcelin11,
L. Assoumou9, C. Katlama1, for the DORAL study group
|
| |
|
|
|
|
|
